OSIL; PDB3; ZIP3; p62; p62B; p60; A170; Paget Disease Of Bone 3; Oxidative Stress Induced Like; EBI3-associated protein of 60 kDa; Ubiquitin-binding protein p62
FceRII; FCER2; BLAST-2; CLEC4J; FCE2; IGEBF; Receptor II For The Fc Region Of Immunoglobulin E; C-type lectin domain family 4 member J; Immunoglobulin E-binding factor; Lymphocyte IgE receptor
CLEC4L; DC-SIGN; CDSIGN; C-Type Lectin Domain Family 4, Member L; Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin
CD66c; NCA; CD66-C; CEAL; Non-Specific Cross Reacting Antigen; Normal cross-reacting antigen
EPO; CLGI; EPA; HCI; Erythroid Potentiating Activity; Collagenase Inhibitor; Metalloproteinase inhibitor 1; Fibroblast collagenase inhibitor
FceRII; FCER2; BLAST-2; CLEC4J; FCE2; IGEBF; Receptor II For The Fc Region Of Immunoglobulin E; C-type lectin domain family 4 member J; Immunoglobulin E-binding factor; Lymphocyte IgE receptor
CD25; IL2R-a; IL2-RA; IDDM10; IL2R; TCGFR; p55; TAC antigen
HABP1; GC1QBP; SF2p32; GC1Q-R; GC1qR; P32; Hyaluronan Binding Protein 1; Splicing Factor SF2-Associated Protein; ASF/SF2-associated p32
p32; CD8-A; Leu2; MAL; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2
PHP14; Phosphohistidine Phosphatase 14kDa; Sex-Regulated Protein Janus-a; Protein janus-A homolog
MHCDRa; HLADRa; Major Histocompatibility Complex Class II DR Alpha
DNAM1; PTA1; TLiSA1; DNAX accessory molecule 1